One more reason to fund the Global Fund

The Lancet

Volumn 379, Issue 9813, 2012, Pages

  Sabot, Oliver ^a   Hall, Shanelle ^a  

^a CLINTON HEALTH ACCESS INITIATIVE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN; CHLOROQUINE;

DEVELOPING COUNTRY; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; LETTER; MALARIA; PRIORITY JOURNAL;

EID: 84856384561     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61756-X     Document Type: Letter

References (5)

1. The Lancet Five reasons to fund the Global Fund Lancet 378 2011 1198
2. B Waning, M Kyle, E Diedrichsen et al. Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets Globalization Health 6 2010 9
3. A Vasan, D Hoos, J Mukherjee, P Farmer, AG Rosenfield, JH Perriens The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund Bull World Health Organ 84 2006 393 398
4. Global Fund to Fight AIDS, Tuberculosis and Malaria 22nd board meeting: report of the Market Dynamics and Commodities Ad Hoc Committee http://www.theglobalfund.org/en/board/meetings/twentysecond/documents/ (accessed Oct 11, 2011).
5. Global Fund to Fight AIDS, Tuberculosis and Malaria 23rd board meeting: report of the Market Dynamics and Commodities Ad Hoc Committee http://www.theglobalfund.org/en/board/meetings/twentythird/documents/ (accessed Nov 15, 2011).